| Filed | Form | Description | |
|---|---|---|---|
| 3/20/26 | DEFA14A | DEFA14A | → |
| 3/20/26 | DEF 14A | DEF 14A | → |
| 3/21/25 | DEF 14A | DEF 14A | → |
| 3/21/25 | DEFA14A | DEFA14A | → |
| 4/11/24 | DEFA14A | DEFA14A | → |
| 4/11/24 | DEF 14A | DEF 14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/6/26 | 4 | 4 | → |
| 3/5/26 | 4 | 4 | → |
| 3/5/26 | 4 | 4 | → |
| 3/5/26 | 3 | FORM 3 | → |
| 3/5/26 | 4 | 4 | → |
| 3/5/26 | 4 | 4 | → |
| ↓ | |||
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland.